Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Journal of Cancer|January 6, 2021
A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancerBoram Han, Bum Jun Kim, Hyeong Su Kim, et al.
Cancer Research and Treatment|January 16, 2018
Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract CancerChanghoon Yoo, Boram Han, Hyeong Su Kim, et al.
Cancer Chemotherapy and Pharmacology|September 16, 2016
A dose-finding study for oxaliplatin, irinotecan, and S-1 (OIS) in patients with metastatic or recurrent gastrointestinal cancerBoram Han, Joo Young Jung, Hyeong Su Kim, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 25, 2010
Excision repair cross-complementation group 1 (ERCC1) expression in advanced urothelial carcinoma patients receiving cisplatin-based chemotherapyKyoung Ha Kim, In-Gu Do, Hyeong Su Kim, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 23, 2015
Phase II study of docetaxel, oxaliplatin, and S-1 therapy in patients with metastatic gastric cancerHyeong Su Kim, Min-Hee Ryu, Dae Young Zang, et al.
Cancer Chemotherapy and Pharmacology|February 5, 2009
Dose-finding study of docetaxel, oxaliplatin, and S-1 for patients with advanced gastric cancerDae Young Zang, Dae Hyun Yang, Min-Jeong Kim, et al.
Cancer Chemotherapy and Pharmacology|August 28, 2013
Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancerHunho Song, Boram Han, Choong Kee Park, et al.
Gastroenterology Research and Practice|February 4, 2016
Second-Line Irinotecan, Leucovorin, and 5-Fluorouracil for Gastric Cancer Patients after Failed Docetaxel and S-1Joo Young Jung, Min-Hee Ryu, Baek-Yeol Ryoo, et al.
Anticancer Research|July 31, 2013
Polycyclic aromatic hydrocarbon-induced oxidative stress, antioxidant capacity, and the risk of lung cancer: a pilot nested case-control studySang-Yong Eom, Dong-Hyuk Yim, Sun In Moon, et al.
Cancer Research and Treatment|February 5, 2015
The Clinical Utility of FDG PET-CT in Evaluation of Bone Marrow Involvement by LymphomaHo Young Kim, Ju-Seok Kim, Dae Ro Choi, et al.
Pageof 14